DENDRIMER-DOXORUBICIN CONJUGATES EXHIBIT IMPROVED ANTICANCER ACTIVITY AND REDUCE DOXORUBICIN-INDUCED CARDIOTOXICITY IN A MURINE HEPATOCELLULAR CARCINOMA MODEL.

Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.

Hepatocellular carcinoma (HCC) is the 2nd leading cause of cancer-related deaths every year globally.The most common form of treatment, hepatic arterial infusion (HAI), involves the direct injection of doxorubicin (DOX) into the hepatic artery.It is plagued with limited therapeutic efficacy and the occurrence of severe toxicities (e.g.cardiotoxicit

read more

Evaluation of the Clinical Effects of an Antiviral, Immunostimulant and Antioxidant Phytotherapy in Patients Suffering from COVID-19 Infection: An Observational Pilot Study

Background: In the last two years, the COVID-19 pandemic has spread all over the world, affecting millions of people.The same infection can manifest in different clinical conditions, ranging from read more mild situations to severe patient impairment, up to their death.The COVID-19 infection can activate innate and adaptive immune systems and cause

read more



Exploring Asymmetric Nexus Between CO2 Emissions, Environmental Pollution, and Household Health Expenditure in China

Muhammad Zeeshan,1 Jiabin Han,1 Alam Rehman,2 Irfan Ullah,3 Fakhr E Alam Afridi4 1College of Business Administration, Liaoning Technical University, Xingcheng, Liaoning Province, 125105, People’s Republic of China; 2Faculty of Management Sciences, National University of Modern Languages, Islamabad, Pakistan; 3Reading Academy, Nanjing Universi

read more